의료기기 수탁제조 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 서비스별, 치료 영역별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)

Medical Device Contract Manufacturing Market Summary

The global medical device contract manufacturing market size was valued at USD 84.61 billion in 2025 and is projected to reach USD 214.33 billion by 2033, growing at a CAGR of 12.58% from 2026 to 2033. The market is experiencing growth driven by growing demand for complex and customized devices, increasing outsourcing trends owing to cost affordability, rising investment in healthcare infrastructure and upsurging off-shoring medical device manufacturing to the emerging economies.

In addition, rising demand for complex, customized devices is fueled by chronic diseases and growth in minimally invasive and wearable technologies. Increasing shift toward personalized medicine is accelerating adoption of advanced manufacturing solutions such as automation, precision engineering, and additive manufacturing. Besides, OEMs are outsourcing to full-service partners in large numbers offering comprehensive capabilities from design to commercialization, reducing time-to-market. In addition, growing regulatory complexity and high compliance costs further boost demand for specialized CMOs.

Furthermore, cost affordability is the major factor driving the medical device contract manufacturing market, as OEMs shift from capital-intensive in-house production to outsourcing. High costs of advanced equipment, cleanrooms, compliance, and skilled labor are pushing companies toward CMOs that offer established infrastructure and expertise. The low-cost manufacturing regions enhance price competitiveness without compromising quality. In addition, CMOs also provide technical expertise and support innovation, enabling OEMs to focus on core activities.

Moreover, offshoring to developing economies is a key driver of the market, as OEMs seek cost efficiency, scalability, and regulatory compliance. Lower labor and operational costs, along with the expansion of manufacturing infrastructure, have encouraged nearly 60% of contract manufacturers to establish operations in emerging regions. In addition, regulatory improvements, including streamlined approvals and supportive policies, have reduced time-to-market and compliance risks. Furthermore, rising healthcare demand, aging populations, and the prevalence of chronic diseases are driving the need for localized, high-volume production. Similarly, favorable macroeconomic factors, such as export incentives and currency advantages, further enhance the appeal of outsourcing.

Global Medical Device Contract Manufacturing Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global medical device contract manufacturing market based on product, services, therapeutic area, end use and region.

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Class I
• Class II
• Class III
• Service Outlook (Revenue, USD Million, 2021 - 2033)
• Accessories Manufacturing
• Assembly Manufacturing
• Component Manufacturing
• Device Manufacturing
• Packaging and Labeling
• Others
• Therapeutic Area Outlook (Revenue, USD Million, 2021 - 2033)
• Cardiovascular Devices
• Orthopedic Devices
• Ophthalmic Devices
• Diagnostic Devices
• Respiratory Devices
• Surgical Instruments
• Dental
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Original Equipment Manufacturers (OEMs)
• Pharmaceutical & Biopharmaceutical Companies
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Oman
  • Qatar

Table of Contents

Chapter 1. Research Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Service
  • 1.2.3. Therapeutic Area
  • 1.2.4. End Use
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information Or Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity Flow Analysis
  • 1.7.2. Top-Down Analysis
  • 1.7.3. Bottom-Up Approach
  • 1.7.4. Multivariate Analysis
• 1.8. List of Secondary Sources
• 1.9. List of Abbreviations
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Medical Device Contract Manufacturing Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Growing Demand for Complex and Customized Devices
    • 3.2.1.2. Increasing Outsourcing Trends Owing to Cost Affordability
    • 3.2.1.3. Rising Investment in Healthcare Infrastructure
    • 3.2.1.4. Upsurging Off-Shoring Medical Device Manufacturing to the Emerging Economies
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Stringent Regulatory Guidelines
    • 3.2.2.2. Compliance Issues While Outsourcing
• 3.3. Technology Landscape
• 3.4. Business Model Analysis
• 3.5. Pricing Model Analysis
• 3.6. Tariff Impact Analysis
• 3.7. Value Chain Analysis
  • 3.7.1. Supply Trends
  • 3.7.2. Demand Trends
• 3.8. Market Analysis Tools
  • 3.8.1. Porter's Five Force Analysis
  • 3.8.2. PESTEL by SWOT Analysis

Chapter 4. Medical Device Contract Manufacturing Market: Product Estimates & Trend Analysis

• 4.1. Medical Device Contract Manufacturing Market, By Product: Segment Dashboard
• 4.2. Medical Device Contract Manufacturing Market, By Product: Movement Analysis
• 4.3. Medical Device Contract Manufacturing Market Estimates & Forecasts, By Product, 2021 - 2033
• 4.4. Class I
  • 4.4.1. Class I Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Class II
  • 4.5.1. Class II Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Class III
  • 4.6.1. Class III Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Medical Device Contract Manufacturing Market: Service Estimates & Trend Analysis

• 5.1. Medical Device Contract Manufacturing Market, By Service: Segment Dashboard
• 5.2. Medical Device Contract Manufacturing Market, By Service: Movement Analysis
• 5.3. Medical Device Contract Manufacturing Market Estimates & Forecasts, By Service, 2021 - 2033
• 5.4. Accessories Manufacturing
  • 5.4.1. Accessories Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Assembly Manufacturing
  • 5.5.1. Assembly Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Component Manufacturing
  • 5.6.1. Component Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. Device Manufacturing
  • 5.7.1. Device Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.8. Packaging and Labeling
  • 5.8.1. Packaging and Labeling Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.9. Others
  • 5.9.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Medical Device Contract Manufacturing Market: Therapeutic Area Estimates & Trend Analysis

• 6.1. Medical Device Contract Manufacturing Market, By Therapeutic Area: Segment Dashboard
• 6.2. Medical Device Contract Manufacturing Market, By Therapeutic Area: Movement Analysis
• 6.3. Medical Device Contract Manufacturing Market Estimates & Forecasts, By Therapeutic Area, 2021 - 2033
• 6.4. Cardiovascular Devices
  • 6.4.1. Cardiovascular Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Orthopedic Devices
  • 6.5.1. Orthopedic Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Ophthalmic Devices
  • 6.6.1. Ophthalmic Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. Diagnostic Devices
  • 6.7.1. Diagnostic Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.8. Respiratory Devices
  • 6.8.1. Respiratory Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.9. Surgical Instruments
  • 6.9.1. Surgical Instruments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.10. Dental
  • 6.10.1. Dental Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.11. Others
  • 6.11.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Medical Device Contract Manufacturing Market: End Use Estimates & Trend Analysis

• 7.1. Medical Device Contract Manufacturing Market, By End Use: Segment Dashboard
• 7.2. Medical Device Contract Manufacturing Market, By End Use: Movement Analysis
• 7.3. Medical Device Contract Manufacturing Market Estimates & Forecasts, By End Use, 2021 - 2033
• 7.4. Original Equipment Manufacturers (OEMs)
  • 7.4.1. Original Equipment Manufacturers (OEMs) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.5. Pharmaceutical & Biopharmaceutical Companies
  • 7.5.1. Pharmaceutical & Biopharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.6. Others
  • 7.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Medical Device Contract Manufacturing Market: Regional Estimates & Trend Analysis

• 8.1. Regional Market Dashboard
• 8.2. Regional Market Share Analysis, 2025 & 2033
• 8.3. North America
  • 8.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.3.2. U.S
    • 8.3.2.1. Key Country Dynamics
    • 8.3.2.2. Competitive Scenario
    • 8.3.2.3. Regulatory Framework
    • 8.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.3.3. Canada
    • 8.3.3.1. Key Country Dynamics
    • 8.3.3.2. Competitive Scenario
    • 8.3.3.3. Regulatory Framework
    • 8.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.3.4. Mexico
    • 8.3.4.1. Key Country Dynamics
    • 8.3.4.2. Competitive Scenario
    • 8.3.4.3. Regulatory Framework
    • 8.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.4. Europe
  • 8.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.2. UK
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competitive Scenario
    • 8.4.2.3. Regulatory Framework
    • 8.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.3. Germany
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competitive Scenario
    • 8.4.3.3. Regulatory Framework
    • 8.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.4. France
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competitive Scenario
    • 8.4.4.3. Regulatory Framework
    • 8.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.5. Italy
    • 8.4.5.1. Key Country Dynamics
    • 8.4.5.2. Competitive Scenario
    • 8.4.5.3. Regulatory Framework
    • 8.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.6. Spain
    • 8.4.6.1. Key Country Dynamics
    • 8.4.6.2. Competitive Scenario
    • 8.4.6.3. Regulatory Framework
    • 8.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.7. Denmark
    • 8.4.7.1. Key Country Dynamics
    • 8.4.7.2. Competitive Scenario
    • 8.4.7.3. Regulatory Framework
    • 8.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.8. Sweden
    • 8.4.8.1. Key Country Dynamics
    • 8.4.8.2. Competitive Scenario
    • 8.4.8.3. Regulatory Framework
    • 8.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.9. Norway
    • 8.4.9.1. Key Country Dynamics
    • 8.4.9.2. Competitive Scenario
    • 8.4.9.3. Regulatory Framework
    • 8.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.2. Japan
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Regulatory Framework
    • 8.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.3. China
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. Regulatory Framework
    • 8.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.4. India
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Scenario
    • 8.5.4.3. Regulatory Framework
    • 8.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.5. Thailand
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Competitive Scenario
    • 8.5.5.3. Regulatory Framework
    • 8.5.5.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.6. South Korea
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Competitive Scenario
    • 8.5.6.3. Regulatory Framework
    • 8.5.6.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.7. Australia
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competitive Scenario
    • 8.5.7.3. Regulatory Framework
    • 8.5.7.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.6. Latin America
  • 8.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.2. Brazil
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory Framework
    • 8.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.3. Argentina
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory Framework
    • 8.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.7. MEA
  • 8.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.2. South Africa
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Scenario
    • 8.7.2.3. Regulatory Framework
    • 8.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.3. Saudi Arabia
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Scenario
    • 8.7.3.3. Regulatory Framework
    • 8.7.3.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.4. UAE
    • 8.7.4.1. Key Country Dynamics
    • 8.7.4.2. Competitive Scenario
    • 8.7.4.3. Regulatory Framework
    • 8.7.4.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.5. Kuwait
    • 8.7.5.1. Key Country Dynamics
    • 8.7.5.2. Competitive Scenario
    • 8.7.5.3. Regulatory Framework
    • 8.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.6. Oman
    • 8.7.6.1. Key Country Dynamics
    • 8.7.6.2. Competitive Scenario
    • 8.7.6.3. Regulatory Framework
    • 8.7.6.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.7. Qatar
    • 8.7.7.1. Key Country Dynamics
    • 8.7.7.2. Competitive Scenario
    • 8.7.7.3. Regulatory Framework
    • 8.7.7.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Key Participant Categorization
  • 9.1.1. Market Leaders
  • 9.1.2. Emerging Players
• 9.2. Market Share/Assessment Analysis, 2025 (Heat Map Analysis)
• 9.3. Company Profiles
  • 9.3.1. Jabil Inc.
    • 9.3.1.1. Company Overview
    • 9.3.1.2. Financial Performance
    • 9.3.1.3. Service Benchmarking
    • 9.3.1.4. Strategic Initiatives
  • 9.3.2. Thermo Fisher Scientific Inc.
    • 9.3.2.1. Company Overview
    • 9.3.2.2. Financial Performance
    • 9.3.2.3. Service Benchmarking
    • 9.3.2.4. Strategic Initiatives
  • 9.3.3. Integer Holdings Corporation
    • 9.3.3.1. Company Overview
    • 9.3.3.2. Financial Performance
    • 9.3.3.3. Service Benchmarking
    • 9.3.3.4. Strategic Initiatives
  • 9.3.4. FLEX LTD.
    • 9.3.4.1. Company Overview
    • 9.3.4.2. Financial Performance
    • 9.3.4.3. Service Benchmarking
    • 9.3.4.4. Strategic Initiatives
  • 9.3.5. Sanmina Corporation
    • 9.3.5.1. Company Overview
    • 9.3.5.2. Financial Performance
    • 9.3.5.3. Service Benchmarking
    • 9.3.5.4. Strategic Initiatives
  • 9.3.6. Celestica Inc.
    • 9.3.6.1. Company Overview
    • 9.3.6.2. Financial Performance
    • 9.3.6.3. Service Benchmarking
    • 9.3.6.4. Strategic Initiatives
  • 9.3.7. Phillips-Medisize
    • 9.3.7.1. Company Overview
    • 9.3.7.2. Financial Performance
    • 9.3.7.3. Service Benchmarking
    • 9.3.7.4. Strategic Initiatives
  • 9.3.8. Plexus Corp.
    • 9.3.8.1. Company Overview
    • 9.3.8.2. Financial Performance
    • 9.3.8.3. Service Benchmarking
    • 9.3.8.4. Strategic Initiatives
  • 9.3.9. Nipro Corporation
    • 9.3.9.1. Company Overview
    • 9.3.9.2. Financial Performance
    • 9.3.9.3. Service Benchmarking
    • 9.3.9.4. Strategic Initiatives
  • 9.3.10. Viant Technology LLC
    • 9.3.10.1. Company Overview
    • 9.3.10.2. Financial Performance
    • 9.3.10.3. Service Benchmarking
    • 9.3.10.4. Strategic Initiatives
  • 9.3.11. West Pharmaceutical Services, Inc.
    • 9.3.11.1. Company Overview
    • 9.3.11.2. Financial Performance
    • 9.3.11.3. Service Benchmarking
    • 9.3.11.4. Strategic Initiatives
  • 9.3.12. Mack Molding
    • 9.3.12.1. Company Overview
    • 9.3.12.2. Financial Performance
    • 9.3.12.3. Service Benchmarking
    • 9.3.12.4. Strategic Initiatives
  • 9.3.13. Cirtec Medical
    • 9.3.13.1. Company Overview
    • 9.3.13.2. Financial Performance
    • 9.3.13.3. Service Benchmarking
    • 9.3.13.4. Strategic Initiatives
  • 9.3.14. Cogmedix
    • 9.3.14.1. Company Overview
    • 9.3.14.2. Financial Performance
    • 9.3.14.3. Service Benchmarking
    • 9.3.14.4. Strategic Initiatives
  • 9.3.15. Synecco Ltd
    • 9.3.15.1. Company Overview
    • 9.3.15.2. Financial Performance
    • 9.3.15.3. Service Benchmarking
    • 9.3.15.4. Strategic Initiatives
  • 9.3.16. TE Connectivity
    • 9.3.16.1. Company Overview
    • 9.3.16.2. Financial Performance
    • 9.3.16.3. Service Benchmarking
    • 9.3.16.4. Strategic Initiatives
  • 9.3.17. Keller Technology Corp.
    • 9.3.17.1. Company Overview
    • 9.3.17.2. Financial Performance
    • 9.3.17.3. Service Benchmarking
    • 9.3.17.4. Strategic Initiatives
  • 9.3.18. HDA Technology, Inc.
    • 9.3.18.1. Company Overview
    • 9.3.18.2. Financial Performance
    • 9.3.18.3. Service Benchmarking
    • 9.3.18.4. Strategic Initiatives